Sponsor Pipeline

Arsenal Biosciences, Inc. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
3
Active Trials
1
Recruiting
3
Disease Areas
Active Trials by Phase
Phase 1/2
2
Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 1/2
NCT07285694 AB-3028, a Programmable Circuit T Cell Therapy in Patients With Castration Resistant… Metastatic Castration Resistant Prostate Cancer (mCRPC) Recruiting
NCT06245915 AB-2100, an Integrated Circuit T Cell Therapy in Patients With Recurrent Clear-cell Renal… Advanced/Metastatic Clear Cell Renal Cell Carcinoma Active, Not Recruiting
Phase 1
NCT05617755 AB-1015, an Integrated Circuit T (ICT) Cell Therapy in Patients With Platinum Resistant… Carcinoma, Ovarian Epithelial Active, Not Recruiting
Disease Areas
Ovarian Cancer (1) Kidney Cancer (1) Prostate Cancer (1)
Get alerts when Arsenal Biosciences, Inc.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free